2026 Trends in Drug Benefit Design Report
PSG announces the results of its extensive research on the latest trends in drug benefit design. Plan sponsors face complex decisions and challenges…
Read Post
Insights
Categories
Topics
Categories
Topics
Let’s Talk COVID-19 Vaccines
As the pandemic continues and COVID-19 cases rise across our nation, it can be challenging to sort through all the news. Promising scientific advances…
Read Post
PSG Position: President Trump’s Latest Executive Order
On November 20, 2020, the Trump administration finalized rules aimed at reducing the costs of drugs. Michael Kolodij, PharmD, unpacks both: “Most Favored…
Read Post
Innovative Diabetes Management Tool Launched by Pharmaceutical Strategies Group
New opportunity to proactively manage the total cost of diabetes care with integrated data on the powerful Artemetrx technology platform PLANO, Texas–(BUSINESS…
Read Post
Let’s Talk Diabetes
Diabetes is a top category of spend for most plan sponsors. According to the American Diabetes Association, people diagnosed with diabetes incur average medical…
Read Post
Real Questions, Real Answers: Understanding the adoption and pipeline for biosimilars
Join the discussion already in progress as we shift gears from last week’s installment on “Unpacking utilization and medical pharmacy integration” to this…
Read Post
Real Questions, Real Answers: What health plans need to know about the state of specialty right now
Another double-digit increase (13.6%) in per member per year cost underscores the need for close monitoring and management of specialty. Successfully partnering with health…
Read Post
Insights into the 2021 PBM Formulary Changes
Thinking back to one year ago, when writing this commentary on the upcoming 2020 formulary changes, no one could have foreseen the challenges and…
Read Post
Pharmaceutical Strategies Group Releases Proprietary Report on State of Specialty Spend and Trend
Actionable insights for specialty drug cost savings delivered in PSG’s fourth annual integrated pharmacy and medical benefit report PLANO, Texas–(BUSINESS WIRE)–Pharmaceutical Strategies Group (PSG)…
Read Post
Upcoming 2021 CVS Formulary Changes
Understanding the importance of delivering “an effective formulary strategy” to achieve cost containment in these challenging times, CVS has revealed their 2021 formulary changes.
Read Post
Upcoming 2021 OptumRx Formulary Changes
Looking toward 2021, OptumRx has announced its formulary changes effective January 1, 2021. These changes will include a combination of downtiers, uptiers, and exclusions…
Read Post
President Trump’s Executive Order on Lowering Drug Prices
Most-Favored-Nation Price for Medicare Back on July 24 of this year, President Trump announced four executive orders taking a variety of approaches to address…
Read Post